Skip to main content
Past Event

Fourth Annual Sentinel Initiative Public Workshop

The Engelberg Center for Health Care Reform at Brookings hosted the Fourth Annual Sentinel Initiative Public Workshop on Wednesday, January 18, at the Washington Marriott in Washington, DC. This public workshop brought together the stakeholder community for a productive discussion on a variety of topics in active medical product surveillance, including an update on the U.S. Food and Drug Administration’s (FDA’s) Sentinel Initiative; efforts to support the advancement of safety science; and stakeholder perspectives on the Sentinel Initiative’s progress and future direction.

Dr. Stephen Spielberg, the FDA’s newly appointed Deputy Commissioner for Medical Products and Tobacco, provided the morning keynote address.


Welcome and Overview

Keynote Address

Overview of the Sentinel Initiative: FDA’s Perspective


Rachel Sherman

Principal, Drug and Biological Drug Products - Greenleaf Health LLC

Update on Mini-Sentinel Activities: One Tool to Promote Drug Safety


Richard Platt

Professor and Chair, Department of Population Medicine - Harvard Pilgrim Health Care Institute


Robert Temple

Deputy Director for Clinical Science, Center for Drug Evaluation and Research - U.S. Food and Drug Administration

Stakeholder Panel Discussion: Managing Expectations and Communicating Findings from Sentinel

Final Remarks

More Information


Get a weekly events calendar from Brookings